Praveen P. Tipirneni M.D.
Net Worth

Last updated:

What is Praveen P. Tipirneni M.D. net worth?

The estimated net worth of Dr. Praveen P. Tipirneni M.D. is at least $10,018,396 as of 8 Jul 2024. He has earned $5,336,796 from insider trading and has received compensation worth at least $4,681,600 in Morphic Holding, Inc..

What is the salary of Praveen P. Tipirneni M.D.?

Dr. Praveen P. Tipirneni M.D. salary is $936,320 per year as Chief Executive Officer, Pres & Director in Morphic Holding, Inc..

How old is Praveen P. Tipirneni M.D.?

Dr. Praveen P. Tipirneni M.D. is 57 years old, born in 1968.

What stocks does Praveen P. Tipirneni M.D. currently own?

As insider, Dr. Praveen P. Tipirneni M.D. owns shares in one company:

Company Title Shares Price per share Total value
Morphic Holding, Inc. (MORF) Chief Executive Officer, Pres & Director 42,460 $0 $0

What does Morphic Holding, Inc. do?

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

MORF logo
MORF
Morphic Holding, Inc.

Praveen P. Tipirneni M.D. insider trading

Morphic Holding, Inc.

Dr. Praveen P. Tipirneni M.D. has made 37 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 29,500 units of MORF stock on 13 Jan 2024. As of 8 Jul 2024 he still owns at least 42,460 units of MORF stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 21,582 $4.32 $93,126
Sale
Common Stock 21,582 $55.79 $1,204,081
Option
Employee Stock Option (right to buy) 21,582 $4.32 $93,126
Sale
Common Stock 13,923 $27.49 $382,757
Option
Restricted Stock Unit 12,500 N/A N/A
Option
Common Stock 12,500 N/A N/A
Option
Restricted Stock Unit 29,500 N/A N/A
Option
Common Stock 29,500 N/A N/A
Sale
Common Stock 1,466 $56.32 $82,570
Option
Stock Option (right to buy Common Stock) 3,597 $4.32 $15,539
Option
Common Stock 3,597 $4.32 $15,539
Sale
Common Stock 493 $57.94 $28,565
Sale
Common Stock 1,638 $57.42 $94,052
Option
Common Stock 3,597 $4.32 $15,539
Sale
Common Stock 3,597 $57.04 $205,176
Option
Stock Option (right to buy Common Stock) 3,597 $4.32 $15,539
Sale
Common Stock 840 $63.01 $52,929
Option
Common Stock 840 $4.32 $3,629
Option
Stock Option (right to buy Common Stock) 840 $4.32 $3,629
Option
Stock Option (right to buy Common Stock) 3,597 $4.32 $15,539
Option
Common Stock 3,597 $4.32 $15,539
Sale
Common Stock 1,609 $57.64 $92,736
Sale
Common Stock 1,988 $56.73 $112,781
Option
Stock Option (right to buy Common Stock) 3,597 $4.32 $15,539
Option
Common Stock 3,597 $4.32 $15,539
Sale
Common Stock 3,597 $51.11 $183,857
Option
Stock Option (right to buy Common Stock) 25,179 $4.32 $108,773
Sale
Common Stock 25,179 $53.4 $1,344,659
Option
Common Stock 25,179 $4.32 $108,773
Option
Restricted Stock Unit 12,500 N/A N/A
Sale
Common Stock 4,027 $30.63 $123,339
Option
Common Stock 12,500 N/A N/A
Sale
Common Stock 19,932 $36.32 $724,010
Option
Stock Option (right to buy Common Stock) 11,932 $4.32 $51,546
Option
Common Stock 11,932 $4.32 $51,546
Sale
Common Stock 8,000 $33.95 $271,624
Option
Common Stock 4,000 $4.32 $17,280
Option
Stock Option (right to buy Common Stock) 4,000 $4.32 $17,280
Option
Stock Option (right to buy Common Stock) 1,653 N/A N/A
Option
Common Stock 1,653 N/A N/A
Sale
Common Stock 3,257 N/A N/A
Option
Common Stock 2,347 N/A N/A
Sale
Common Stock 4,743 N/A N/A
Option
Stock Option (right to buy Common Stock) 2,347 N/A N/A
Sale
Common Stock 2,342 N/A N/A
Option
Stock Option (right to buy Common Stock) 2,268 N/A N/A
Option
Common Stock 2,268 N/A N/A
Sale
Common Stock 440 N/A N/A
Option
Common Stock 200 N/A N/A
Option
Stock Option (right to buy Common Stock) 200 N/A N/A
Sale
Common Stock 440 $19.66 $8,652
Option
Stock Option (right to buy Common Stock) 1,000 N/A N/A
Option
Common Stock 1,000 N/A N/A
Sale
Common Stock 2,259 N/A N/A
Sale
Common Stock 7,027 N/A N/A
Option
Common Stock 600 N/A N/A
Option
Stock Option (right to buy Common Stock) 600 N/A N/A
Option
Stock Option (right to buy Common Stock) 4,000 N/A N/A
Sale
Common Stock 8,000 N/A N/A
Option
Common Stock 4,000 N/A N/A
Option
Common Stock 654 $30 $19,620
Sale
Common Stock 996 $30 $29,880
Sale
Common Stock 996 N/A N/A
Option
Common Stock 654 N/A N/A
Option
Stock Option (right to buy Common Stock) 327 N/A N/A
Option
Common Stock 5,426 N/A N/A
Sale
Common Stock 8,143 $21.51 $175,132
Sale
Common Stock 8,143 N/A N/A
Option
Stock Option (right to buy Common Stock) 2,713 N/A N/A
Option
Common Stock 5,426 $17.21 $93,376
Option
Stock Option (right to buy Common Stock) 200 N/A N/A
Option
Common Stock 200 N/A N/A
Sale
Common Stock 500 N/A N/A
Option
Stock Option (right to buy Common Stock) 300 N/A N/A
Sale
Common Stock 341 N/A N/A
Option
Common Stock 300 N/A N/A
Sale
Common Stock 860 N/A N/A
Option
Common Stock 460 N/A N/A
Sale
Common Stock 860 $17.16 $14,758
Option
Stock Option (right to buy Common Stock) 460 N/A N/A
Sale
Common Stock 5,103 N/A N/A
Option
Stock Option (right to buy Common Stock) 2,508 N/A N/A
Option
Common Stock 2,508 N/A N/A
Option
Stock Option (right to buy Common Stock) 4,367 N/A N/A
Sale
Common Stock 8,698 N/A N/A
Option
Common Stock 4,367 N/A N/A
Sale
Common Stock 13,168 N/A N/A
Option
Common Stock 6,643 N/A N/A
Option
Stock Option (right to buy Common Stock) 6,643 N/A N/A
Sale
Common Stock 13,168 $15.59 $205,236
Option
Common Stock 6,100 N/A N/A
Sale
Common Stock 12,338 N/A N/A
Option
Stock Option (right to buy Common Stock) 6,100 N/A N/A
Sale
Common Stock 5,180 N/A N/A
Option
Stock Option (right to buy Common Stock) 2,605 N/A N/A
Option
Common Stock 2,605 N/A N/A
Option
Common Stock 7,777 N/A N/A
Sale
Common Stock 15,513 N/A N/A
Option
Stock Option (right to buy Common Stock) 7,777 N/A N/A

Morphic Holding key executives

Morphic Holding, Inc. executives and other stock owners filed with the SEC: